Financing ·
Milestone Scientific Inc. received notices of conversion from directors Benedetta Casamento, Dr. Didier Demesmin, and…
MLSSMilestone Scientific Inc.
Milestone Scientific Inc. received notices of conversion from directors Benedetta Casamento, Dr. Didier Demesmin, and Neal Goldman regarding their remaining Convertible Bridge Notes. The outstanding principal amounts subject to conversion are $116,495.47 for Ms. Casamento, $58,247.73 for Dr. Demesmin, and $291,238.66 for Mr. Goldman. These conversions will become effective automatically when the common stock's fair value reaches at least $0.50 per share and compliance with insider trading policies is met. No shares have been issued as of the filing date. Milestone Scientific Inc. operates in the medical device industry, developing minimally invasive surgical technologies.